The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
about
The H19 non-coding RNA is essential for human tumor growthLong noncoding RNAs in gastric cancer: functions and clinical applicationsLong Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical TranslationPossible physiological role of H19 RNAThe Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian CancerTranscriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers.Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancerUse of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic CancerTargeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequencesDevelopment of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequencesElevated expression of H19 and Igf2 in the female mouse eye.Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JARAltered DNA methylation patterns of the H19 differentially methylated region and the DAZL gene promoter are associated with defective human sperm.The functional role of long non-coding RNA in human carcinomas.H19 expression in hepatic metastases from a range of human carcinomas.Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissueCirculating Long Noncoding RNA as a Potential Target for Prostate CancerPredicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNAH19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer.The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.Long noncoding RNAs in diseases of aging.H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activationExpression of the h19 oncofetal gene in premalignant lesions of cervical cancer: a potential targeting approach for development of nonsurgical treatment of high-risk lesionsDevelopment of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequencesLong non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer.IRWRLDA: improved random walk with restart for lncRNA-disease association prediction.H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer CellsRole of long non-coding RNAs in normal and malignant hematopoiesis.Functional significance of long non-coding RNAs in breast cancer.An emerging role for long non-coding RNAs in cancer metastasisLong noncoding RNAs: a potential novel class of cancer biomarkers.A critical overview of long non-coding RNA in glioma etiology 2016: an update.lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.Genomic Insight into the Role of lncRNA in Cancer Susceptibility.Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: possible insights from emerging technology.
P2860
Q21144433-94A9B695-BF7E-4E74-B47E-6951480A9B53Q26765291-993F9F5D-AFAC-409C-930D-211F39C9F0E5Q28071872-EA8CB986-CA35-494B-AAA4-43ADB5331123Q28204018-130E20F9-5C17-4A9D-AC02-735097872AE2Q28833833-A960E1F0-0C47-4F70-91A0-01DB92D18502Q30467807-F71FC01B-93F4-44FE-BA53-894BDC45B815Q31147380-B07A0B9E-05BE-4466-8A6C-5121B6D43CEFQ33670900-AFCFDC4E-1E5B-49AC-AA65-BEAC366E2BC7Q34259980-81A96706-ACF3-403B-BBD6-C5550C482328Q34271222-E333855D-55B0-449C-B3E4-6F6E72F8CE87Q34467904-DD88A13C-1CFD-42B3-B590-97D2BBC0FCA1Q34599086-F0801BBE-CC19-4417-A7BA-0BA0D7B8EB6FQ34742149-27B3C3E4-27FD-4A13-B87F-13FA707F719AQ34981288-17B0F351-E807-44F5-83AE-DF4B703F6526Q34995156-0540463A-76B7-48BE-B2A3-69DA7934AC58Q35588750-1E323BDD-B06B-44FF-BEF4-49A1204F7D43Q35747814-9151034B-4039-45F4-8720-7BF695D71240Q35763168-AB43538E-7BDE-4296-BA0A-00183CD2A151Q35792008-1045029F-2794-4FC3-A52A-112BF9469E98Q35814012-2E0D5AA3-222B-4EC8-BE03-EFE216B71C66Q35961138-1476EA92-B43F-4C75-B6E9-248E8530A4E2Q36021781-7F582998-4E1A-49AD-9DD5-467DB305A697Q36116407-3CA0564F-6A91-4170-94AB-596041CB20BAQ36261274-C8444C1C-D754-4CA8-8702-6848A64D4FE6Q36422024-C007C967-489D-4E03-85F8-24FDBC6A4AA4Q36827714-14395B78-0461-4CCD-BA4A-C2D3F7EDE410Q37105364-6EC8EF3C-D95E-475D-AF2A-8C8BFB193273Q37325540-AC5D50C5-2660-4FF2-8630-596F1897094EQ37349438-94854803-3BD9-413A-8997-316CFD189D34Q37628955-F2AA3C0B-85F3-4643-90FA-13005B5ED715Q37634278-31421B0C-8681-432A-8BE0-99C80F4435BAQ38136969-0222C250-0014-421E-B2D0-BD07B04F7C34Q38231209-2B80E041-FDB2-49E0-8ADB-7B1B4753F9A4Q38237645-2A2A5614-67B6-4B09-A691-5FEC478B8FECQ38466810-FD8F66AF-A44F-4564-AA67-A3C1AD5678F5Q38954633-B3DAAB97-D2F0-4940-B883-7F741730796CQ38978723-F34BA590-338C-4FD8-AB78-CDACB43C59CDQ39031286-2158CF7B-5F75-4EC1-AF99-75B207F0DA83Q39362053-956979CA-BAA0-46E7-9277-21E4730F2E52Q40473214-A4B2378B-F648-4EB9-B29C-4FBEAF5A374A
P2860
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
@nl
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@ast
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@en
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@en-gb
type
label
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
@nl
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@ast
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@en
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@en-gb
prefLabel
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
@nl
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@ast
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@en
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
@en-gb
P2093
P2860
P3181
P356
P1476
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
@en
P2093
A Hochberg
B A Libdeh
M L Tykocinski
N de Groot
P2860
P304
P3181
P356
10.1136/MP.53.6.320
P407
P577
2000-12-01T00:00:00Z